CBN has exactly one personality trait in the cannabis world: it puts you to sleep. That reputation is partly earned and partly oversimplified. Yes, CBN is associated with sedation. No, the research doesn’t fully explain why yet. The honest version is more interesting than the marketing version: CBN’s sleep connection involves THC oxidation, terpene synergy, and a body of research that’s promising but still building. This guide covers what CBN actually is, how it forms, what the science says about sleep, and how it compares to CBD and THC for nighttime use.
🧪 Lab Tested | 👩💼 Woman-Owned | 🏆 Est. 2017
CBN at a Glance
| Full name | Cannabinol (CBN) |
| Source | Forms naturally as THC oxidizes and degrades over time in cannabis plants |
| Psychoactive? | Mildly; roughly one-tenth the potency of THC at CB1 receptors. Most users don’t report a high at typical doses. |
| Primary reputation | Sedation and sleep support |
| Research status | Promising but limited; most sleep evidence is preclinical or observational |
| Federal legal status | Legal when hemp-derived under the 2018 Farm Bill |
| Common formats | Gummies, tinctures (often paired with CBD) |
| Drug test risk | Lower than THC products; CBN itself differs metabolically from THC, but verify COA shows non-detectable THC before using if tested |
| TribeTokes CBN rating | 4.57/5 from 49 verified CBN product reviews |
What Is CBN?
Cannabinol (CBN) is a cannabinoid produced by the cannabis plant, but not in the way most cannabinoids are. CBN isn’t synthesized directly in the plant. It’s a degradation product: it forms when Delta-9 THC is exposed to heat, light, or oxygen over time and breaks down. The older and more poorly stored the cannabis, the higher its CBN content.
This origin story is part of why CBN carries its sleep reputation. Older, degraded cannabis was long reported anecdotally to be more sedating than fresh material. Researchers attributed this to the increased CBN content. That reasoning was plausible but turned out to be incomplete. The sleep science section goes deeper on why.
CBN was actually the first cannabinoid ever isolated from cannabis, in 1896, decades before THC and CBD were identified. It sat largely unstudied for most of the 20th century. Research interest has picked up significantly since 2015 as the broader cannabis research landscape has opened up, though CBN still has far fewer controlled human trials than CBD.
Source: Mechoulam, R. and Gaoni, Y. (1967). “Recent Advances in the Chemistry of Hashish.” Fortschritte der Chemie Organischer Naturstoffe, 25, 175-213.
How CBN Forms
THC doesn’t stay THC forever. When Delta-9 THC is exposed to heat, ultraviolet light, or oxygen, it oxidizes: the molecular structure changes as oxygen atoms are incorporated and hydrogen atoms are lost. The resulting compound is cannabinol (CBN).
This process happens slowly under normal conditions. Fresh cannabis contains very little CBN. Cannabis that’s been stored improperly, exposed to light, or simply aged for years accumulates higher CBN concentrations. Lab analyses of well-preserved cannabis across different storage conditions have documented this conversion reliably. Roughly 25-30% of THC converts to CBN over several years under typical conditions.
For commercial CBN products, producers don’t wait around for THC to age out. CBN is typically synthesized through controlled oxidation of hemp-derived THC or directly isomerized from CBD, then refined and formulated into consumer products. The end result is the same molecule regardless of the production path.
One practical implication: if you’ve ever noticed that older cannabis felt more sedating or produced a “heavier” effect than fresh material, CBN accumulation is one possible explanation. It’s not the only one (terpene profiles also shift during aging), but it’s part of the picture.
Source: Turner, C.E. et al. (1973). “Constituents of Cannabis sativa L. IV. Stability of cannabinoids in stored plant material.” Journal of Pharmaceutical Sciences, 62(10), 1601-1605. PubMed: 4750299.
How CBN Works in the Body
CBN interacts with the endocannabinoid system (ECS) primarily through CB1 and CB2 receptors, the same receptor targets as THC and CBD, but through different mechanisms and with different intensity.
CBN is a partial agonist at CB1 receptors, the same receptor type that THC activates strongly to produce psychoactive effects. But CBN binds with significantly lower affinity than THC: roughly one-tenth the potency by most estimates. At the doses used in typical CBN products (5-25mg), most users don’t report a noticeable psychoactive effect. Some describe a mild body relaxation or drowsiness. A distinct “high” in the THC sense is uncommon at standard doses.
CBN also activates CB2 receptors, which are concentrated in immune tissues rather than the brain. CB2 activity is associated with anti-inflammatory effects and immune modulation, an area of active research interest for CBN, separate from its sleep reputation.
Beyond the ECS, CBN appears to interact with TRPV channels involved in pain and temperature regulation, and with GABA receptors that govern inhibitory signaling in the brain, though the extent of these interactions at physiologically relevant doses is still being characterized in research.
Source: Nachnani, R. et al. (2021). “The Pharmacological Case for Cannabigerol.” Journal of Pharmacology and Experimental Therapeutics, 376(2), 204-212. Note: general ECS receptor interaction data for minor cannabinoids including CBN referenced in this review context. PubMed: 33168643.
The Sleep Science: What the Research Actually Says
CBN’s sleep reputation runs well ahead of the published research. That’s not a reason to dismiss it. It’s a reason to understand it accurately.
What Started the Reputation
The original connection between CBN and sedation came largely from anecdotal reports about aged cannabis producing heavier, more sedating effects than fresh material. Since CBN accumulates as THC degrades, researchers assumed CBN was the responsible agent. A 1975 study suggested synergy between CBN and THC in producing sedation in mice, which circulated widely in the cannabis literature and cemented CBN’s sleepy identity for decades.
What the Research Actually Shows
In 2021, researcher James Corroon published a systematic review specifically examining the CBN-sleep connection, the most thorough analysis of the available evidence at the time. His conclusion: the existing research was insufficient to establish CBN as a reliable sleep aid on its own. Most studies were in animal models, used CBN in combination with other cannabinoids, or relied on self-reported outcomes without controls. The 1975 mouse study, for instance, tested a CBN/THC combination rather than CBN alone.
Separately, Ethan Russo, a neurologist and cannabinoid researcher who has written extensively on the entourage effect, has suggested that the sedation associated with aged cannabis may be driven more by terpene profiles than by CBN content. Myrcene in particular, a terpene with documented sedative properties in preclinical research, is often present in higher relative concentrations in aged plant material. This doesn’t mean CBN has no sleep effects. It means the mechanism is more complex than “CBN = sleep.”
Where the Research Is Heading
More recent research is taking a more rigorous approach. A 2023 study at the University of Sydney examined CBN’s effects on sleep in older adults and found some evidence of subjective sleep improvement, though the sample was small and the results were preliminary. Preclinical research in animals consistently shows sedative-adjacent effects from CBN, particularly in combination with other cannabinoids. Human trials are underway.
The honest position: CBN’s sleep reputation is not fabricated. Something is clearly happening for many users: the anecdotal evidence is strong and consistent, including in TribeTokes reviews. But calling CBN a proven sleep aid would be overstatement. Calling it a promising one, with a plausible mechanism and growing research interest, is accurate.
Sources: Corroon, J. (2021). “Cannabinol and Sleep: Separating Fact from Fiction.” Cannabis and Cannabinoid Research, 6(5), 366-371. PubMed: 34468204. | Russo, E.B. (2011). “Taming THC: Potential cannabis synergies and phytocannabinoid-terpenoid entourage effects.” British Journal of Pharmacology, 163(7), 1344-1364. PubMed: 21749363.
CBN vs. CBD vs. THC for Sleep
| CBN | CBD | THC (Delta 8 or Delta 9) | |
| Psychoactive? | Mildly; 1/10th the potency of THC. Most users feel relaxation, not a high. | No | Yes |
| Primary sleep mechanism | CB1 partial agonism; possible terpene synergy; mechanism still under study | Anxiolytic effects via serotonin receptors; may reduce REM disruption at higher doses | CB1 activation promotes sleep onset; can affect REM sleep architecture at higher doses |
| Research quality | Promising but limited; mostly preclinical | Stronger evidence base; human trials on anxiety and sleep | Well-documented short-term sleep onset effects; long-term use more complex |
| Next-day grogginess? | Low at typical doses; users generally report waking refreshed | Minimal at wellness doses | Possible at higher doses; varies by individual and dose |
| Drug test risk | Lower than THC; verify COA shows non-detectable THC in product | Low with broad-spectrum or isolate; verify non-detectable THC on COA | High; will produce positive result |
| Best combined with | CBD (most TribeTokes CBN products are CBD-boosted); myrcene-rich terpenes | CBN for deeper sleep effect; CBG for focus during day | CBD to moderate intensity; indica terpenes for sleep |
In practice, most people who use cannabinoids for sleep end up combining them rather than choosing one. A CBD/CBN stack (which is how TribeTokes formulates both the CBN gummies and the tincture) gives you CBD’s anxiolytic effects alongside CBN’s sedative properties, at doses where neither causes next-day grogginess. Elsie S. described the shift: “In the past year my sleep pattern has been so bad, now I sleep through the night and wake up refreshed.” That pattern (better sleep without the morning heaviness) shows up consistently in the review data.
THC (particularly indica-dominant Delta 8 or Delta 9 products) works for sleep onset very effectively, but at higher doses it can suppress REM sleep. Regular nightly users should factor that in. CBN and CBD don’t appear to have the same REM suppression effect at typical doses, which is part of why they attract interest as alternatives or complements.
CBN Formats
CBN Gummies
Gummies are the most popular CBN format. Taken 45-90 minutes before sleep, they deliver a sustained release of CBN and CBD through digestive processing, which means slower onset than sublingual delivery but longer duration. The sleep support window for a gummy taken around 9pm typically runs through the night rather than peaking and fading quickly. Tamika W.: “I cannot be without these gummies. Thank you TribeTokes. Feels good to sleep again.” Julia E.: “I am sleeping better and I don’t wake up with a headache anymore.”
CBN Tincture
Tinctures are held under the tongue (sublingually) for 60-90 seconds before swallowing. Some of the CBN and CBD absorbs through the mucous membrane directly into the bloodstream, bypassing digestion entirely. Onset is 15-45 minutes, faster than gummies but with a slightly shorter duration window. Tinctures also allow more precise dose adjustment than the fixed-dose gummies. “Within 5 minutes I can feel myself slowly closing my eyes. It also helps me go back to sleep if I wake,” wrote Heather B. That speed is consistent with sublingual absorption.
Which Format?
Gummies for consistent nightly use with longer coverage. Tincture for faster onset or when you want to adjust dose by half-dropper increments. Many users use both: a tincture sublingually at bedtime plus a gummy an hour before to layer the timing.
How to Dose CBN
| User type | Starting range | Notes |
| New to CBN | 5-10mg CBN per night | TribeTokes CBN gummies are 10mg CBN per gummy. Start with one. Give it 3-5 nights before adjusting. |
| Occasional use | 10-20mg CBN | One or two gummies, or a half-dropper of tincture. Take 60-90 minutes before target sleep time for gummies; 30-45 minutes for tincture. |
| Regular nightly use | 10-25mg CBN | Most regular users land in this range. Mary C. uses half a dropper of tincture paired with a small amount of Delta 8, a reasonable combination approach. |
| Lighter sensitivity | 5mg or less | Cut a gummy in half. CBN is mildly psychoactive; some people are more sensitive than others, especially if they haven’t used cannabinoids before. |
Timing matters more with CBN than with most cannabinoids. For sleep onset, take gummies 60-90 minutes before you want to be asleep, not at bedtime. The digestive window means you’re still awake when they kick in if you wait too long. Tincture is more forgiving on timing: 30-45 minutes is usually sufficient.
CBN pairs well with CBD. The TribeTokes CBN products are formulated as CBD-CBN combinations specifically because most users report better results from the combination than from either alone. This is consistent with the entourage effect principle: cannabinoids working better together than in isolation.
CBN and Drug Testing
CBN differs metabolically from THC. The metabolites that standard immunoassay drug tests target (primarily THC-COOH) are specific to Delta-9 THC metabolism. CBN metabolizes through a different pathway and produces different metabolites. In theory, pure CBN products should not trigger a standard urine drug screen.
In practice, the risk depends on product composition, not just the presence of CBN. Two things to check before using any CBN product if you’re subject to drug testing:
Verify non-detectable THC on the batch COA. TribeTokes CBN products are formulated with hemp-derived CBD and CBN; the COAs confirm non-detectable Delta-9 THC. But formulation matters: a CBN product that contains even trace THC could accumulate with regular use.
Know your test type. Older or lower-quality immunoassay panels have been documented to show cross-reactivity with some cannabinoid metabolites other than THC-COOH. This is less common with modern testing panels but not impossible. If your testing context is high-stakes (workplace, legal, athletic), consult with your testing authority before using any cannabinoid product including CBN.
The bottom line: CBN products with verified non-detectable THC carry significantly lower drug test risk than any THC-containing product. They are not, however, a guaranteed pass. Verify the COA, know your test, and make the call with full information.
What to Look for When Buying CBN
CBN products are a smaller, less regulated category than CBD, which means quality varies more and the basics matter extra here.
Full-panel COA from an accredited lab. Same standard as any cannabinoid product: potency plus heavy metals, pesticides, residual solvents, and microbials. A COA that only confirms CBN content tells you almost nothing useful. More importantly for CBN specifically, the COA should confirm non-detectable Delta-9 THC if you have any drug testing concern.
Confirmed CBN content. Many “CBN products” on the market are primarily CBD with a tiny amount of CBN added for marketing purposes. Check the actual CBN milligrams per serving on the COA, not just the label. A meaningful dose is 5mg CBN or more per serving.
CBD pairing. CBN works better in combination with CBD than alone, based on both user reports and the entourage effect research. Products formulated as CBD+CBN combinations are the standard worth looking for. Isolated CBN products exist but have less reported efficacy per milligram in practice.
Live resin vs. standard extract. TribeTokes CBN gummies use live resin extraction, which preserves the full terpene profile alongside the CBN and CBD. This matters for the entourage effect: myrcene and other sedative-associated terpenes in the live resin profile may contribute meaningfully to the sleep effect, consistent with Russo’s terpene-synergy hypothesis.
TribeTokes CBN Products
TribeTokes offers two CBN products, both formulated as CBD-CBN combinations with third-party batch testing and COAs published at tribetokes.com/certificates-of-analysis.
CBN Live Resin Gummies are 10mg CBN + CBD per gummy in a peach live resin formula. The live resin extraction preserves the full terpene profile. Deborah W.: “I especially love the 1:1 of CBD and CBN.” The flavor comes through clearly and the gummies don’t have the artificial sweetness of some CBD/CBN edibles. Rima A.: “The most amazing gummies that help put you right to sleep. The flavor is great and they truly work.”
CBN Tincture for Sleep is a 1,800mg full-spectrum CBD-boosted tincture formulated for sublingual use before bed. It allows half-dropper dose adjustment for people who want more precision than a fixed-dose gummy allows. Frances M.: “This tincture absolutely does the job. I get fantastic sleep.” Claudia B.: “This really seems to be improving my sleep.”
Both products are available at tribetokes.com/cbn-sleep-gummies or through the full CBN product collection. 4.57/5 from 49 verified CBN purchaser reviews. Woman-owned since 2017.
Frequently Asked Questions About CBN
CBN (cannabinol) is a cannabinoid that forms when Delta-9 THC oxidizes and degrades over time. It’s not synthesized directly in fresh cannabis plants; it’s a byproduct of THC aging when exposed to heat, light, or oxygen. Older or improperly stored cannabis tends to have higher CBN content. For commercial products, CBN is typically produced through controlled oxidation of hemp-derived THC or isomerization from CBD. CBN was actually the first cannabinoid ever isolated from cannabis, in 1896, though it received little research attention until recently.
At typical doses, no. CBN is a partial agonist at CB1 receptors (the same receptor that THC activates to produce psychoactive effects), but with roughly one-tenth the binding potency of THC. At 5-25mg doses typical in CBN products, most users describe mild body relaxation or drowsiness rather than any distinct high. At higher doses, some mild psychoactive effects are possible. CBN is not marketed or used as a recreational intoxicant, and its non-intoxicating reputation at normal doses is generally accurate.
Many users report that it does, and the anecdotal evidence is consistent across a large number of people. The science is more cautious. A 2021 systematic review by researcher James Corroon found the existing human research insufficient to definitively establish CBN as a standalone sleep aid. Most studies were in animals, used CBN in combination with other cannabinoids, or lacked controls. That said, research is ongoing, and the combination of CBN with CBD and myrcene-rich terpenes (as in live resin formulations) may produce more meaningful effects than isolated CBN alone. The practical reality is that many people find it helpful for sleep; whether that’s CBN specifically or the entourage combination is still being studied.
Both are non-intoxicating cannabinoids (CBN mildly so; CBD fully), but they have different mechanisms and reputations. CBD works primarily through serotonin receptors, TRPV1 channels, and FAAH inhibition; it’s studied mainly for anxiety, pain, and inflammation. CBN works primarily through CB1 and CB2 receptor partial agonism and is studied mainly for sleep. CBD has a much larger body of human clinical research than CBN. For sleep specifically, many users and formulators combine both because the mechanisms appear complementary: CBD’s anxiolytic effects reduce the mental activation that prevents sleep onset, while CBN contributes more directly to sedation.
For gummies: 60-90 minutes before your target sleep time. The digestive processing window means a gummy taken right at bedtime may not peak until 1-2 hours later, which is too late for sleep onset. For a tincture held sublingually: 30-45 minutes before sleep is usually sufficient, since some absorption happens through the mucous membrane before digestion. If you’re waking in the middle of the night and having trouble getting back to sleep, a tincture is more practical for 2am use than a gummy: it works faster.
CBN metabolizes differently than THC and its metabolites differ from THC-COOH, which is what standard drug screens target. Pure CBN products that contain non-detectable THC on a verified COA are significantly lower risk than any THC-containing product. However, this is not a guaranteed pass: some older immunoassay panels have shown cross-reactivity with non-THC cannabinoid metabolites, and any product containing trace THC carries accumulation risk. Verify the batch COA shows non-detectable Delta-9 THC, know what testing panel you’ll face, and consult your testing authority if the stakes are high.
For most people new to CBN, 5-10mg per night is a reasonable starting point. TribeTokes CBN gummies contain 10mg CBN per gummy; start with one and give it 3-5 nights before adjusting. CBN’s sleep effects can take a few nights to become consistent as the body adjusts. If you feel nothing after a week at 10mg, move to 15-20mg. If you feel groggy the next morning, reduce to half a gummy. The tincture format allows more precise adjustment in smaller increments than gummies do.
Yes, when derived from hemp. Hemp-derived CBN is federally legal under the 2018 Farm Bill in the United States, as long as the product contains 0.3% or less Delta-9 THC by dry weight. TribeTokes CBN products are hemp-derived and third-party tested to confirm legal compliance. Most states align with federal law on hemp-derived cannabinoids including CBN, though regulations continue to evolve. Check current state law if you have specific concerns.
CBN is metabolized through the liver’s CYP450 enzyme system, which also processes many common medications. At low doses, this interaction is unlikely to be significant for most medications. That said, pairing CBN with prescription sedatives, sleep medications, or medications that carry grapefruit interaction warnings warrants a conversation with your healthcare provider before starting. This is not a reason to avoid CBN, but it is a reason to check.
Format, onset speed, and duration. Gummies are digested before absorbing, which means 45-90 minute onset and longer duration through the night, better for people who fall asleep normally but want sustained coverage. Tinctures held sublingually absorb faster (15-45 minutes), offer finer dose control, and are more practical if you need something quickly at 2am. Many people use both: a gummy taken before bed and a tincture kept on the nightstand for middle-of-the-night wake-ups.
Shop TribeTokes CBN Products
Live resin CBN gummies and full-spectrum CBN tincture. CBD-boosted, batch-tested, formulated for sleep. Woman-owned since 2017.
Sources
- Mechoulam, R. and Gaoni, Y. (1967). “Recent Advances in the Chemistry of Hashish.” Fortschritte der Chemie Organischer Naturstoffe, 25, 175-213.
- Turner, C.E. et al. (1973). “Constituents of Cannabis sativa L. IV. Stability of cannabinoids in stored plant material.” Journal of Pharmaceutical Sciences, 62(10), 1601-1605. PubMed: 4750299.
- Corroon, J. (2021). “Cannabinol and Sleep: Separating Fact from Fiction.” Cannabis and Cannabinoid Research, 6(5), 366-371. PubMed: 34468204.
- Russo, E.B. (2011). “Taming THC: Potential cannabis synergies and phytocannabinoid-terpenoid entourage effects.” British Journal of Pharmacology, 163(7), 1344-1364. PubMed: 21749363.